Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2014-03-24
Original SEC Filing: Click here

---

Webplus: SVA/20140324/6-K/2_EX-99.1/000.htm SEC Original: v372478_ex99-1.htm
Sinovac Files Clinical Trial Application with CFDA for its Proprietary Vaccine — -Preclinical development completed for H7N9 vaccine candidates that addresses significant BEIJING, January 29, 2014—Sinovac Biotech Ltd. (Nasdaq:SVA), a leading provider of biopharmaceutical products in China, announced today that it has submitted a Clinical Trial Application(CTA) with the China Food and Drug Administration(CFDA) to commence human clinical trials for

---

---

Webplus: SVA/20140324/6-K/3_EX-99.2/000.htm SEC Original: v372478_ex99-2.htm
Sinovac’s EV71 Vaccine Phase III Clinical Trial Results Published in New — Study shows vaccine provides protection against EV71-associated hand, foot and mouth th The New England Journal of Medicine BEIJING, Feb. 26, 2014 /PRNewswire/ — Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today that Phase III clinical trial results for its proprietary

---

---

Webplus: SVA/20140324/6-K/4_EX-99.3/000.htm SEC Original: v372478_ex99-3.htm
Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2013 BEIJING, March 12, 2014 — Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the fourth quarter and whole year ended December 31, 2013, after market closes on Wednesday, March 19, 2014

---

---

Webplus: SVA/20140324/6-K/5_EX-99.4/000.htm SEC Original: v372478_ex99-4.htm
Sinovac Reports Unaudited Fourth Quarter and Full Year 2013 Financial Results – Conference call scheduled for Thursday, March 20, 2014 at 8:00 AM EDT – BEIJING, March 19, 2014 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited fourth quarter and full year financial results for the period ended December

---

---

Webplus: SVA/20140324/6-K/1/000.htm SEC Original: v372478_6k.htm

---

Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2014-03-24CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085